Regulus Therapeutics Inc. - Common Stock (NQ:RGLS)

8.160 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Regulus Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q1 2024 ↗

May 09, 2024

RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028 ↗

May 07, 2024

Finding good investing possibilities in the constantly changing stock market might be likened to unearthing buried jewels.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 06, 2024

Via Benzinga

RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q4 2023 ↗

March 21, 2024

RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP

March 13, 2024

Via AB Newswire

Analyst Expectations for Regulus Therapeutics's Future ↗

September 21, 2023

Via Benzinga

Expert Ratings for Regulus Therapeutics ↗

June 28, 2023

Via Benzinga

Earnings Outlook For Regulus Therapeutics ↗

March 08, 2023

Via Benzinga

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 14, 2024

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.

Via Benzinga

Gold Down Over 1%; ClearOne Shares Spike Higher ↗

March 12, 2024

U.S. stocks traded higher toward the end of trading, with the S&P 500 index gaining over 1% on Tuesday. The Dow traded up 0.74% to 39,057.10 while the NASDAQ rose 1.41% to 16,245.83. The S&P 500 also...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 12, 2024

Via Benzinga

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 12, 2024

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Via Benzinga

Nasdaq Surges Over 1%; Blade Air Mobility Shares Plummet ↗

March 12, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Tuesday. The Dow traded up 0.48% to 38,955.84 while the NASDAQ rose 1.12% to 16,198.58. The S&P 500 also...

Via Benzinga

Topics Stocks

Regulus Therapeutics Inc. (NASDAQ: RGLS) is One of Tuesday Morning’s Most Active Stocks

March 12, 2024

Via Investor Brand Network

Dow Gains 100 Points; US Inflation Rate Rises To 3.2% In February ↗

March 12, 2024

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.27% to 38,873.55 while the NASDAQ rose...

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 12, 2024

Via Benzinga

Why Is Kidney Disease-Focused Regulus Therapeutics Stock Trading Higher On Tuesday? ↗

March 12, 2024

Regulus Therapeutics reports findings for RGLS8429 in ADPKD study—mechanistic dose response, encouraging biomarkers, and an oversubscribed $100M equity placement at $1.60 per share.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 12, 2024

Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 21, 2023

Via Benzinga

Regulus Therapeutics Releases Early Data From Of Investigational For Rare Type Of Kidney Disease ↗

September 20, 2023

Regulus Therapeutics Inc (NASDAQ: RGLS) released topline results from the first cohort of patients in its Phase 1b Multiple-Ascending Dose (MAD) trial of RGLS8429 for Autosomal Dominant Polycystic

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 17, 2023

Via Benzinga

Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket ↗

April 17, 2023

Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 17, 2023

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 13, 2023

Via Benzinga

Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 13, 2023

Gainers CXApp Inc. (NASDAQ: CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday.

Via Benzinga

Why Regulus Therapeutics Shares Are Trading Higher Today ↗

April 13, 2023

Regulus Therapeutics (NASDAQ: RGLS) shares are trading higher on Thursday after the company announced a $15 million private placement of equity.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 17, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.